800-680-7137Call For Help With Addiction
Talk To Someone Now
- Find a Clinic Near You
- Access Help and Resources
- Get 24-Hour Guidance and Information
SponsoredNo results found!
Medication Treatment for Opioid Use Disorder in Arbutus
Arbutus is a small community in southwestern Baltimore County, close to the Baltimore City line and the UMBC campus, making a wide range of treatment accessible within a short drive. People looking for medication for opioid use disorder (MOUD) here are rarely limited to a single option.
Opioid treatment programs, office-based prescribers, and telehealth all operate across this part of the county. The listings on this page are the place to start, and the sections below explain what each treatment setting involves so you can tell what those listings offer before you call.
Three Medications, Two Settings
Opioid use disorder can be treated with three FDA-approved medications, and the setting depends on which one you and your clinician choose. Methadone for opioid use disorder is dispensed only through a federally certified opioid treatment program (OTP), the setting many people still call a methadone clinic, and not at a retail pharmacy.
Buprenorphine, which includes Suboxone (a buprenorphine-naloxone combination) and the monthly Sublocade injection, can be prescribed in a doctor’s office and filled at a pharmacy, or inside an OTP.
Naltrexone, including the monthly Vivitrol injection, is not a controlled substance and any licensed prescriber can order it. However, you must be off opioids long enough first to avoid precipitated withdrawal, a sharp worsening of symptoms that happens when the medication is started too soon.
If you are weighing the first two against each other, it helps to read a plain comparison of methadone and Suboxone, or a fuller explanation of what an opioid treatment program actually does. Which medication fits is a decision you make with a clinician, not something to decide alone.
Starting Care Without a Long Wait
The first step is usually an intake assessment, where a clinician confirms the diagnosis, reviews your history, and in most cases starts medication the same day. At an OTP, that visit is in person. When you are using buprenorphine, an office visit or virtual appointment is possible. The prescription is filled at a local pharmacy the same day.
If you have been using fentanyl, the timing of a first buprenorphine dose matters, because starting too soon can trigger precipitated withdrawal, so plan that timing with the clinician rather than guessing. You do not need to arrive with paperwork or a referral to ask about how treatment is started after fentanyl use. Calling a provider on this page is enough to begin treatment.
Take-Home Doses and Telehealth Rules
Federal rules updated in 2024 expanded take-home methadone, up to a 28-day supply for patients who are stable in treatment, with eligibility decided by the program based on how your treatment is going. The same update allowed treatment to begin via telehealth and removed older barriers to getting admitted.
For buprenorphine, current federal rules in effect through the end of 2026 allow treatment to be started by telehealth, including by phone in many cases, without a prior in-person visit. A permanent buprenorphine telemedicine rule took effect at the end of 2025 and runs alongside that extension.
Methadone for opioid use disorder is still dispensed in person through an OTP. Because these rules are still being finalized, confirm current options with the provider you choose. People transferring in from another program can ask about how ongoing methadone treatment is managed so a move does not interrupt dosing.
Paying for Treatment
Maryland Medicaid, known as HealthChoice, covers all three medications for opioid use disorder, with substance use care administered through the state’s Public Behavioral Health System.
The 2024 Consolidated Appropriations Act made the requirement that Medicaid cover every FDA-approved MOUD permanent, so that coverage is no longer time-limited. Many private plans and Medicare also cover treatment, and OTPs commonly offer self-pay or sliding-scale arrangements.
Exact details, such as preferred medications or any prior authorization, vary by plan, so confirm specifics with the provider before your first visit.
The Overdose Picture in Baltimore County
Local numbers are moving in an encouraging direction. Baltimore County recorded 200 fatal overdoses in 2024, down from 286 in 2023, a 30% drop, and a 49% decline since 2021, according to the Maryland Overdose Data Dashboard as reported by the Baltimore County Department of Health.
These are county-level figures rather than Arbutus-specific counts, and fentanyl remains the substance driving most opioid deaths in the region. The point of the number is not alarm but direction: the decline tracks with wider naloxone distribution and better access to medication treatment, and effective care is available close to home. For background on the condition itself, see how opioid use disorder develops.
Families, Young Adults, and Confidentiality
Arbutus sits next to a large university community, and families are often the first ones to call for a young adult. Medication treatment is the recommended standard of care, not a matter of willpower, and it is worth knowing that substance use treatment records carry stronger privacy protections than most medical records under federal rule 42 CFR Part 2.
A provider generally needs written consent to share information. During pregnancy, medication treatment is recommended before, during, and after the child is born. Maryland’s MOM Program offers enhanced case management through Medicaid managed care.
If you are supporting someone, guidance written for families covers how to help without pushing a person away, and methadone during pregnancy addresses perinatal care directly.
Naloxone and Overdose Safety
Naloxone, the medication that reverses an opioid overdose, is easy to get in Maryland. A statewide standing order updated in August 2025 allows any licensed pharmacist to dispense it, including over-the-counter Narcan, to anyone, with no prescription and no prior training.
Baltimore County also runs free public health vending machines stocked with naloxone and fentanyl test strips, funded through opioid settlement dollars. Maryland’s Good Samaritan Law protects someone who calls 911 during an overdose from arrest on several drug-related charges.
A return to use can happen in any chronic condition and is a reason to stay connected to care, not a failure; keeping naloxone on hand is simple protection. See what to do during an opioid overdose.
Common Questions
Do I have to go to a clinic every day?
Not necessarily. Methadone starts with more frequent visits, but stable patients can earn take-home doses, up to a 28-day supply, under the 2024 federal rules. Buprenorphine prescribed in an office does not involve daily clinic visits at all, since it is filled at a pharmacy.
Is same-week treatment realistic near Arbutus?
Often yes. Many providers do same-day or same-week intake, and buprenorphine can sometimes be started by telehealth. Availability varies by provider, so call the listings on this page to ask directly.
Can I get methadone at a pharmacy?
No, under current federal law, methadone for opioid use disorder is dispensed only through a certified opioid treatment program. Buprenorphine and naltrexone are the medications that can be filled at a pharmacy. You can read more in common questions about methadone treatment.
Will treatment last forever?
There is no set endpoint. Many people stay on medication long term because it works, and long-term treatment is legitimate care. Decisions about when and whether treatment ends are made with a clinician over time.
Last reviewed and sources
Last reviewed July 2026.
Sources for this page:
- Baltimore County Department of Health, “Baltimore County Experiencing Significant Decline in Overdose Deaths,” April 2025, citing the Maryland Overdose Data Dashboard. https://www.baltimorecountymd.gov/departments/county-executive/news/baltimore-county-experiencing-significant-decline-overdose-deaths
- Maryland Department of Health, Pharmacy Naloxone Standing Order and Guidance, issued August 28, 2025. https://health.maryland.gov/pha/NALOXONE/Documents/Pharmacy-Naloxone-Standing-Order-and-Guidance.pdf
- SAMHSA, Medications for Opioid Use Disorder overview and 42 CFR Part 8 final rule (2024). https://www.samhsa.gov/substance-use/treatment/opioid-treatment-program/42-cfr-part-8
- Drug Enforcement Administration and HHS, Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities (effective January 1 to December 31, 2026) and Expansion of Buprenorphine Treatment via Telemedicine Encounter final rule (effective December 31, 2025). https://www.federalregister.gov/documents/2025/12/31/2025-24123/fourth-temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled
This site is not a medical provider and does not provide medical advice, diagnosis, or treatment. The content here is for general informational purposes only; decisions about medication, dose, and care should be made with a licensed clinician.
Calls placed to the helpline number on this site may be answered by a paid advertiser, and the helpline is a referral service. Use of the helpline does not guarantee placement at any particular treatment center, and we do not receive a commission tied to any specific provider in the directory listings on this page.
Last Updated: August 5, 2026